Literature DB >> 28586933

A Case of Pituitary Carcinoma Initially Diagnosed as an Ectopic Growth Hormone Producing Pituitary Adenoma with a High Ki-67 Labeling Index.

Toshiki Endo1, Yoshikazu Ogawa2, Mika Watanabe3, Teiji Tominaga1.   

Abstract

We report a case of a 66-year-old woman with a malignant transformation of a growth hormone (GH)-producing pituitary adenoma that was mainly located in the clivus. The patient originally presented with left oculomotor and abducens nerve palsies. Magnetic resonance imaging revealed a clival tumor separated from the normal pituitary gland, and the patient subsequently underwent transsphenoidal surgery. Analysis of the resected clival tissue revealed proliferation of tumor cells with slightly irregular nuclei but no mitosis. Although the Ki-67 labeling index was as high as 8.7%, p53 was negative. Histologic analysis confirmed the diagnosis of a GH-producing pituitary adenoma. Two months after the first operation, the tumor acutely enlarged and caused a subarachnoid hemorrhage. Pathologic findings of the second surgical specimen showed significant nuclear atypia. The Ki-67 labeling index increased to 27.7% and the p53 was positive; there was no GH immunoreactivity. Following the second surgical intervention, the patient was diagnosed with an atypical pituitary adenoma and underwent postoperative local radiotherapy (50 Gy in 25 fractions). Twenty months after the first surgery, multiple bone metastases were detected that led to the diagnosis of pituitary carcinoma. This is the first report of a clival pituitary adenoma undergoing malignant transformation. Because neuroimaging may underestimate local invasiveness in ectopic pituitary tumors, it is essential to conduct a histologic examination to evaluate it. Further analysis of similar cases is necessary to improve clinical management for this confused diagnostic criterion. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28586933     DOI: 10.1055/s-0037-1600515

Source DB:  PubMed          Journal:  J Neurol Surg A Cent Eur Neurosurg        ISSN: 2193-6315            Impact factor:   1.268


  5 in total

1.  Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?

Authors:  Yoshikazu Ogawa; Hidefumi Jokura; Kuniyasu Niizuma; Teiji Tominaga
Journal:  J Neurooncol       Date:  2018-01-09       Impact factor: 4.130

Review 2.  Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature.

Authors:  C Campana; F Nista; L Castelletti; M Caputo; E Lavezzi; P Marzullo; A Ferrero; G Gaggero; F R Canevari; D C Rossi; G Zona; A Lania; D Ferone; F Gatto
Journal:  J Endocrinol Invest       Date:  2022-02-11       Impact factor: 5.467

3.  Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma.

Authors:  Brigita Glebauskiene; Rasa Liutkeviciene; Alvita Vilkeviciute; Inga Gudinaviciene; Aurelija Rocyte; Dovile Simonaviciute; Ruta Mazetyte; Loresa Kriauciuniene; Dalia Zaliuniene
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

4.  Correlation Analysis of Magnetic Resonance Imaging Characteristics and Prognosis of Invasive Pituitary Adenomas in Neurosurgery Hospitals.

Authors:  Jinan Bai; Xin Li; Ailiang Ge; Jianhua Gu
Journal:  J Healthc Eng       Date:  2022-04-21       Impact factor: 3.822

5.  A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review.

Authors:  Peng Du; Xuefan Wu; Kun Lv; Ji Xiong; Daoying Geng
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.